Therapy with antibodies against CD40L (CDI54) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide

Jon Laman, CBM (Kitty) Maassen, MM Schellekens, L Visser, M Kap, E de Jong, M van Puijenbroek, MJB van Stipdonk, Marjan van Meurs, C Schwärzler, U Günthert

Research output: Contribution to journalArticleAcademic

Original languageUndefined/Unknown
Pages (from-to)147-153
Number of pages7
JournalMultiple Sclerosis
Volume4
Publication statusPublished - 1998

Cite this